<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 1998
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
------- --------
Commission File Number 0-21447
ADVANCE PARADIGM, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
Delaware 75-2493381
(State of Incorporation) (IRS Employer Identification Number)
545 E. John Carpenter Freeway, Suite 1570, Irving, Texas 75062
(Address of principal executive offices) (ZIP Code)
</TABLE>
(972) 830-6199
(Registrant's Telephone Number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
YES X NO
--- ---
Common stock, $.01 par value: 10,264,280
outstanding as of November 12, 1998
<PAGE> 2
ADVANCE PARADIGM, INC.
INDEX TO QUARTERLY REPORT FORM 10-Q
<TABLE>
<CAPTION>
PART I. FINANCIAL INFORMATION PAGE
<S> <C>
Item 1. Financial Statements
A. Condensed Consolidated Balance Sheets as of
September 30, 1998 and March 31, 1998 2
B. Condensed Consolidated Statements of Operations
for the Three Months and Six Months Ended
September 30, 1998 and 1997 3
C. Condensed Consolidated Statements of Cash
Flows for the Six Months Ended
September 30, 1998 and 1997 4
D. Notes to Condensed Consolidated Financial Statements 5
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations 7
PART II. OTHER INFORMATION 12
SIGNATURES 14
</TABLE>
<PAGE> 3
ADVANCE PARADIGM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
<TABLE>
<CAPTION>
March 31, 1998 September 30, 1998
----------------- ------------------
ASSETS
<S> <C> <C>
CURRENT ASSETS:
Cash and cash equivalents $ 58,342,000 $ 38,106,000
Accounts receivable, net of allowance for doubtful accounts of
$247,000 and $259,000, respectively 68,335,000 97,450,000
Inventories 2,887,000 2,591,000
Prepaid expenses and other 1,487,000 1,788,000
----------------- -----------------
Total current assets 131,051,000 139,935,000
PROPERTY AND EQUIPMENT, net of accumulated depreciation
and amortization of $5,574,000 and $6,909,000, respectively 10,494,000 12,063,000
INTANGIBLE ASSETS, net of accumulated amortization of
$1,501,000 and $1,674,000, respectively 12,353,000 12,179,000
OTHER ASSETS 1,011,000 925,000
----------------- -----------------
Total assets $ 154,909,000 $ 165,102,000
================= =================
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $ 97,495,000 $ 101,777,000
Accrued salaries and benefits 2,966,000 3,019,000
Income taxes payable 32,000 --
Other accrued expenses 2,196,000 1,358,000
----------------- -----------------
Total current liabilities 102,689,000 106,154,000
NONCURRENT LIABILITIES:
Deferred income taxes 1,285,000 1,657,000
Other noncurrent liabilities 371,000 371,000
----------------- -----------------
Total liabilities 104,345,000 108,182,000
----------------- -----------------
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Series B convertible preferred stock, $.01 par value; 5,000 shares
authorized, 4,444 and 0 shares issued and
outstanding, respectively -- --
Common stock, $.01 par value; 25,000,000
shares authorized; 8,904,472 and 10,256,554
shares issued and outstanding, respectively 89,000 103,000
Additional paid-in capital 43,142,000 43,612,000
Retained earnings 7,333,000 13,205,000
----------------- -----------------
Total stockholders' equity 50,564,000 56,920,000
----------------- -----------------
Total liabilities and stockholders' equity $ 154,909,000 $ 165,102,000
================= =================
</TABLE>
See accompanying notes to financial statements.
- 2 -
<PAGE> 4
ADVANCE PARADIGM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended September 30, Six Months Ended September 30,
-------------------------------------- --------------------------------------
1997 1998 1997 1998
----------------- ----------------- ----------------- -----------------
<S> <C> <C> <C> <C>
Revenues $ 116,508,000 $ 181,258,000 $ 195,911,000 $ 345,440,000
----------------- ----------------- ----------------- -----------------
Cost of operations:
Cost of revenues 111,724,000 173,727,000 187,262,000 330,869,000
Selling, general and
administrative expenses 2,416,000 3,312,000 4,527,000 6,575,000
----------------- ----------------- ----------------- -----------------
Total cost of operations 114,140,000 177,039,000 191,789,000 337,444,000
----------------- ----------------- ----------------- -----------------
Operating income 2,368,000 4,219,000 4,122,000 7,996,000
Interest income 726,000 708,000 1,398,000 1,474,000
Interest expense (23,000) -- (42,000) --
----------------- ----------------- ----------------- -----------------
Income before income taxes 3,071,000 4,927,000 5,478,000 9,470,000
Provision for income taxes 1,167,000 1,872,000 2,081,000 3,598,000
----------------- ----------------- ----------------- -----------------
Net income $ 1,904,000 $ 3,055,000 $ 3,397,000 $ 5,872,000
================= ================= ================= =================
Basic
Net income per share $ 0.21 $ 0.30 $ 0.38 $ 0.58
================= ================= ================= =================
Weighted average
shares outstanding 8,683,645 10,256,554 8,681,395 10,084,528
================= ================= ================= =================
Diluted
Net income per share $ 0.17 $ 0.27 $ 0.30 $ 0.51
================= ================= ================= =================
Weighted average
shares outstanding 11,305,863 11,499,250 11,146,029 11,596,387
================= ================= ================= =================
</TABLE>
See accompanying notes to financial statements.
- 3 -
<PAGE> 5
ADVANCE PARADIGM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
Six Months Ended September 30,
----------------------------------
1997 1998
--------------- ---------------
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 3,397,000 $ 5,872,000
Adjustments to reconcile net income to
net cash provided by operating activities -
Depreciation and amortization 1,094,000 1,508,000
Provision for doubtful accounts 12,000 12,000
Change in certain assets and liabilities -
Accounts receivable (14,344,000) (29,127,000)
Inventories (53,000) 296,000
Prepaid expenses
and other assets (1,453,000) (215,000)
Accounts payable, accrued expenses
and other noncurrent liabilities 18,085,000 3,837,000
--------------- ---------------
Net cash provided by (used in) operating activities 6,738,000 (17,817,000)
--------------- ---------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment (3,084,000) (2,904,000)
--------------- ---------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of Common Stock 28,000 485,000
Proceeds from borrowings 583,000 --
Payments on long-term obligations (583,000) --
--------------- ---------------
Net cash provided by financing activities 28,000 485,000
--------------- ---------------
INCREASE (DECREASE) IN CASH 3,682,000 (20,236,000)
CASH AND CASH EQUIVALENTS, beginning of period 51,172,000 58,342,000
--------------- ---------------
CASH AND CASH EQUIVALENTS, end of period $ 54,854,000 $ 38,106,000
=============== ===============
</TABLE>
See accompanying notes to financial statements.
- 4 -
<PAGE> 6
ADVANCE PARADIGM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited condensed consolidated financial statements
have been prepared by the Company in accordance with generally accepted
accounting principles for interim financial information and substantially in
the form prescribed by the Securities and Exchange Commission (the
"Commission") in instructions to Form 10-Q and Article 10 of Regulation S-X.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.
In the opinion of the Company's management, the September 30, 1998 and 1997
unaudited interim financial statements include all adjustments, consisting of
normal recurring adjustments, necessary for a fair presentation of results for
this interim period. In the opinion of the Company's management, the
disclosures contained in this Form 10-Q are adequate to make the information
presented not misleading when read in conjunction with the Notes to
Consolidated Financial Statements included in the Company's Form 10-K for the
year ended March 31, 1998. The results of operations for the three month and
six month periods ended September 30, 1998 are not necessarily indicative of
the results to be expected for the full year or for any future period.
2. NET INCOME PER SHARE
Net income per share is computed using the weighted average number of
common and dilutive shares outstanding during the period. A reconciliation of
the numerators and denominators of the basic and diluted per share computations
are as follows:
- 5 -
<PAGE> 7
<TABLE>
<CAPTION>
THREE MONTHS ENDED SEPTEMBER 30, SIX MONTHS ENDED SEPTEMBER 30,
-------------------------------- -------------------------------
1997 1998 1997 1998
-------------- --------------- -------------- --------------
<S> <C> <C> <C> <C>
BASIC
Numerator:
Net income $ 1,904,000 $ 3,055,000 $ 3,397,000 $ 5,872,000
Preferred stock dividends 50,000 -- 100,000 --
-------------- -------------- -------------- --------------
$ 1,854,000 $ 3,055,000 $ 3,297,000 $ 5,872,000
============== ============== ============== ==============
Denominator:
Weighted average common
stock outstanding 8,683,645 10,256,554 8,681,395 10,084,528
============== ============== ============== ==============
Net income per share $ 0.21 $ 0.30 $ 0.38 $ 0.58
============== ============== ============== ==============
DILUTED
Numerator:
Net income $ 1,904,000 $ 3,055,000 $ 3,397,000 $ 5,872,000
============== ============== ============== ==============
Denominator:
Weighted average common 8,683,645 10,256,554 8,681,395 10,084,528
stock outstanding
Other dilutive securities:
Series B preferred stock 1,111,111 -- 1,111,111 73,260
Options and warrants using the
treasury stock method 1,511,107 1,242,696 1,353,523 1,438,599
-------------- -------------- -------------- --------------
Weighted average shares outstanding 11,305,863 11,499,250 11,146,029 11,596,387
============== ============== ============== ==============
Net income per share $ 0.17 $ 0.27 $ 0.30 $ 0.51
============== ============== ============== ==============
</TABLE>
3. INCOME TAXES
In the three months and six months ended September 30, 1997 and 1998, the
Company recorded a provision for income taxes based upon an estimated,
effective tax rate of 38%.
- 6 -
<PAGE> 8
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
The following table sets forth certain consolidated financial data of the
Company, for the periods indicated, as a percentage of total revenues.
<TABLE>
<CAPTION>
Three Months Six Months
Ended September 30, Ended September 30,
----------------------------- -----------------------------
1997 1998 1997 1998
------------ ------------ ------------ ------------
<S> <C> <C> <C> <C>
Data Services 68.2% 66.1% 64.5% 67.6%
Mail Services 15.4 16.5 18.0 16.5
Clinical Services 16.4 17.4 17.5 15.9
------------ ------------ ------------ ------------
Total Revenues 100.0 100.0 100.0 100.0
------------ ------------ ------------ ------------
Cost of operations:
Cost of revenues 95.9 95.9 95.6 95.8
Selling, general and administrative
expenses 2.1 1.8 2.3 1.9
------------ ------------ ------------ ------------
Total cost of operations 98.0 97.7 97.9 97.7
------------ ------------ ------------ ------------
Operating income 2.0 2.3 2.1 2.3
Interest income, net of expense .6 .4 .7 .4
------------ ------------ ------------ ------------
Income before income taxes 2.6 2.7 2.8 2.7
Provision for income taxes (1.0) (1.0) (1.1) (1.0)
------------ ------------ ------------ ------------
Net income 1.6% 1.7% 1.7% 1.7%
============ ============ ============ ============
</TABLE>
THREE MONTHS ENDED SEPTEMBER 30, 1998 COMPARED TO THREE MONTHS ENDED
SEPTEMBER 30, 1997
REVENUES. Revenues for the three months ended September 30, 1998 increased
$64.8 million, or 56%, compared to revenues for the three months ended
September 30, 1997. Approximately 62% of the increase in revenues was
attributable to a 30% increase in the number of pharmacy claims processed
during the period. The increase in claims resulted from new contracts signed
throughout the last twelve months with new clients, as well as internal growth
from existing clients. Substantially all of the new clients utilize the
Company's pharmacy network. In cases in which the Company has an independent
obligation to pay its network pharmacy providers, the Company includes payments
from its plan sponsors for these benefits as revenues and payments to its
pharmacy providers as cost of revenues. Therefore, new clients that utilize the
Company's network will generate higher revenues than new business where the
Company merely administers the client's network. The increase in claims
resulted from strong growth in new clients and from an increase in member lives
from existing clients. Approximately 19% of the increase in revenues was
attributable to additional sales of the Company's mail pharmacy services,
resulting from a 61% increase in the number of mail prescriptions dispensed.
The remaining 19% of the increase in revenues resulted from an increase in
clinical services revenues derived from formulary and disease management
services as well as clinical trials.
- 7 -
<PAGE> 9
COST OF REVENUES. Cost of revenues for the three months ended September
30, 1998 increased by $62.0 million, or 55%, compared to the same period in the
prior year. This increase was attributable primarily to the additional costs
associated with the Company's claims processing growth and the new clients that
are utilizing the Company's retail pharmacy network. As a percentage of
revenues, cost of revenues was approximately 95.9% in the three months ended
September 30, 1998 and 1997.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
administrative expense for the three months ended September 30, 1998 increased
by $896,000, or 37%, compared to the same period in the prior year. This
increase was the result of the Company's expansion of its sales and marketing
activities, as well as increases in administrative and support staff levels and
salaries and benefits in response to volume growth in all services. In spite of
the increase, selling, general and administrative expenses as a percentage of
revenues decreased from 2.1% for the three months ended September 30, 1997 to
1.8% in the same period in 1998 as the result of greater economies of scale and
due to the increase in revenues associated with the Company's claims processing
services. Additional revenues generated by clients utilizing the Company's
network pharmacy providers typically do not result in an increase in selling,
general and administrative expenses.
INTEREST INCOME AND INTEREST EXPENSE. Interest income, net of interest
expense, for the three months ended September 30, 1998 increased $5,000
compared to the same period in the prior year. The Company incurred no interest
expense in the three months ended September 30, 1998 since the Company had no
outstanding indebtedness during the period.
INCOME TAXES. For the three months ended September 30, 1998 and 1997 the
Company recorded income tax expense based upon an estimated, effective tax rate
of 38%.
NET INCOME PER SHARE. The Company reported diluted net income per share of
$.27 per share for the three months ended September 30, 1998 compared to $.17
per share for the same period in the prior year. The weighted average shares
outstanding were 11.3 million and 11.5 million for the three months ended
September 30, 1997 and 1998, respectively. The increase in the weighted average
shares resulted primarily from the increase in the Company's stock price which
has resulted in more options and warrants becoming dilutive securities. (See
Note 2 for calculation.)
- 8 -
<PAGE> 10
SIX MONTHS ENDED SEPTEMBER 30, 1998 COMPARED TO SIX MONTHS ENDED
SEPTEMBER 30, 1997
REVENUES. Revenues for the six months ended September 30, 1998 increased
$149.5 million, or 76%, compared to revenues for the six months ended September
30, 1997. Approximately 71% of the increase in revenues was attributable to a
33% increase in the number of pharmacy claims processed during the period. The
increase in claims resulted from new contracts signed throughout the last
twelve months with new clients, as well as internal growth from existing
clients. Substantially all of the new clients utilize the Company's pharmacy
network. In cases in which the Company has an independent obligation to pay its
network pharmacy providers, the Company includes payments from its plan
sponsors for these benefits as revenues and payments to its pharmacy providers
as cost of revenues. Therefore, new clients that utilize the Company's network
will generate higher revenues than new business where the Company merely
administers the client's network. The increase in claims resulted from strong
growth in new clients and from an increase in member lives from existing
clients. Approximately 15% of the increase in revenues was attributable to
additional sales of the Company's mail pharmacy services, resulting from a 58%
increase in the number of mail prescriptions dispensed. The remaining 14% of
the increase in revenues resulted from an increase in clinical services
revenues derived from formulary and disease management services as well as
clinical trials.
COST OF REVENUES. Cost of revenues for the six months ended September 30,
1998 increased by $143.6 million, or 77%, compared to the same period in the
prior year. This increase was attributable primarily to the additional costs
associated with the Company's claims processing growth and the new clients that
are utilizing the Company's retail pharmacy network. As a percentage of
revenues, cost of revenues was approximately 95.8% in the six months ended
September 30, 1998 compared to 95.6% in the same period in the prior year.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
administrative expense for the six months ended September 30, 1998 increased by
$2.0 million, or 45%, compared to the same period in the prior year. This
increase was the result of the Company's expansion of its sales and marketing
activities, as well as increases in administrative and support staff levels and
salaries and benefits in response to volume growth in all services. In spite of
the increase, selling, general and administrative expenses as a percentage of
revenues decreased from 2.3% for the six months ended September 30, 1997 to
1.9% in the same period in 1998 as the result of greater economies of scale and
due to the increase in revenues associated with the Company's claims processing
services. Additional revenues generated by clients utilizing the Company's
network pharmacy providers typically do not result in an increase in selling,
general and administrative expenses.
- 9 -
<PAGE> 11
INTEREST INCOME AND INTEREST EXPENSE. Interest income, net of interest
expense, for the six months ended September 30, 1998 increased $118,000
compared to the same period in the prior year. The Company incurred no interest
expense in the three months ended September 30, 1998 since the Company had no
outstanding indebtedness during the period. The increase also resulted from
higher cash balances invested in cash management programs which utilized the
Company's short-term excess cash to generate interest income through investment
in money market funds and high-grade commercial paper. The increase in interest
income was reduced due to lower interest rates in the six months ended
September 30, 1998 compared to the prior year.
INCOME TAXES. For the six months ended September 30, 1998 and 1997 the
Company recorded income tax expense based upon an estimated, effective tax rate
of 38%.
NET INCOME PER SHARE. The Company reported diluted net income per share of
$.51 per share for the six months ended September 30, 1998 compared to $.30 per
share for the same period in the prior year. The weighted average shares
outstanding were 11.1 million and 11.6 million for the six months ended
September 30, 1997 and 1998, respectively. The increase in the weighted average
shares resulted primarily from the increase in the Company's stock price which
has resulted in more options and warrants becoming dilutive securities. (See
Note 2 for calculation.)
LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 1998, the Company had working capital of $33.8
million. The Company's net cash used in operating activities was $17.8 million
for the six months ended September 30, 1998 due to the timing of the collection
of certain receivables and the payment of certain payables prior to the end of
the quarter. During the six months ended September 30, 1998 the Company used
cash of $2.9 million for purchases of property, plant and equipment associated
with the growth and expansion of the Company's systems and facilities. The
Company anticipates that cash from operations, combined with the proceeds
remaining from its initial public offering will be sufficient to meet the
Company's internal operating requirements and expansion programs, including
capital expenditures, for at least the next 18 months.
YEAR 2000 ISSUES
The Company's operations are dependent upon its computer systems and
information technology. In fiscal year 1998 the Company began addressing the
Year 2000 issue by forming a Year 2000 project team. Year 2000 compliance
relates to: technology, including but not limited to, information technology,
embedded systems, or any other electro-mechanical or processor-based system.
Such technology, when used in accordance with its associated documentation, is
capable of accurately processing, providing and/or receiving date data from,
into and between the twentieth and twenty-first centuries, and the years 1999
and 2000, including leap year calculations. In the quarter ending June 30,
1998, the Company completed the "inventory" portion of its Year 2000 project.
The Company documented all internal hardware, software or equipment that was
date sensitive.
- 10 -
<PAGE> 12
In the quarter ending September 30, 1998, the Company completed the second
stage of the Year 2000 project which involved assessing all of the items that
had been "inventoried" to determine whether they were Year 2000 compliant. This
assessment stage also included surveying all external vendors and customers
that transact business with the Company to determine whether their systems were
Year 2000 compliant.
The third stage involves the development of code to convert systems that
are not compliant to Year 2000 compliant systems. This stage is expected to be
completed by the end of November 1998. The final stage involves the testing of
all technical systems to verify Year 2000 compliance. All systems are expected
to be tested and implemented by the end of March 1999.
The Company has and will incur internal and external personnel costs as
well as other expenses related to this project. Although the Company is still
evaluating the overall costs associated with the Year 2000 project, the Company
does not believe the associated costs are or will be material to the Company's
results of operations or financial condition. However, there can be no
assurance that the Company's efforts to address the Year 2000 issue will be
entirely successful. In addition, there can be no assurance that the software
and systems of other companies from which the Company transacts business will
become Year 2000 compliant in a timely manner. Any such failures could have a
material adverse effect on the Company's systems and operations.
FORWARD-LOOKING STATEMENTS
This report contains or may contain forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934 including
statements of the Company's and management's expectations, intentions, plans
and beliefs, including those contained in or implied by "Management's
Discussion and Analysis of Financial Condition and Results of Operations" and
the Notes to Condensed Consolidated Financial Statements. These forward-looking
statements, as defined in Section 21E of the Securities Exchange Act of 1934,
are dependent on certain events, risks and uncertainties that may be outside
the Company's control. These forward-looking statements may include statements
of management's plans and objectives for the Company's future operations and
statements of future economic performance; the Company's capital budget and
future capital requirements, and the Company's meeting its future capital
needs; and the assumptions described in this report underlying such
forward-looking statements. Actual results and developments could differ
materially from those expressed in or implied by such statements due to a
number of factors, including, without limitation, those described in the
context of such forward-looking statements, and the factors set forth in the
Company's Form 10-K under the caption "Risk Factors." All subsequent written
and oral forward-looking statements attributable to the Company or persons
acting on its behalf are expressly qualified in their entirety by this section.
- 11 -
<PAGE> 13
PART II. OTHER INFORMATION
Items 1-3 are not applicable.
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The annual meeting of stockholders was held on October 29, 1998. At the close
of business on September 18, 1998, the record date of those entitled to vote at
the meeting, there were 10,179,354 shares of Common Stock issued and
outstanding.
David D. Halbert, Jon S. Halbert and Rogers K. Coleman, M. D. were re-elected
directors of the Company to serve until the Annual Meeting of Stockholders in
2001 and until their respective successors are elected and qualified.
The stockholder vote for each director elected at the meeting was as follows:
<TABLE>
<CAPTION>
Votes Cast Votes
For Withheld
---------- --------
<S> <C> <C>
David D. Halbert 8,403,121 318,080
Jon S. Halbert 8,379,485 341,716
Rogers K. Coleman, M. D 8,378,890 342,311
</TABLE>
The stockholders also voted to approve an Amendment to the Advance
Paradigm, Inc. Amended and Restated Incentive Stock Option Plan to increase the
number of shares available for issuance thereunder from 1,859,000 to 2,359,000
(5,975,041 affirmative votes; 2,702,796 negative votes; 43,364 abstention
votes)
The stockholders also voted to ratify the appointment of Arthur
Andersen as the Company's independent accountants for the Company's current
fiscal year (8,716,114 affirmative votes; 2,480 negative votes; 2,607
abstention votes)
Item 5. OTHER INFORMATION
On October 12, 1998, the Company and Blue Cross Blue Shield of Texas,
Inc. ("BCBS of Texas") agreed to cancel the warrant agreement, dated November
25, 1995, entered into by and between BCBS of Texas and the Company. No
warrants were earned or issued to BCBS of Texas under such warrant agreement.
Effective as of June 12, 1998, the Company issued a warrant to
Wellmark, Inc. ("Wellmark") representing the right to acquire up to 56,250
shares of Common Stock at a per share exercise price equal to $32 5/8 per
share. Twenty percent of the total shares covered by the warrant will vest on
January 1, 1999 and an additional twenty percent will vest on January 1 of each
of the following four years, subject to certain terms and conditions. The term
of the warrant expires on December 31, 2003. As of November 12, 1998, no shares
under the warrant had been exercised or issued.
-12-
<PAGE> 14
Item 6. Exhibits and reports on Form 8-K.
No reports on Form 8-K were filed during the quarter ended September 30, 1998.
Exhibits required by Item 601 of S-K:
EXHIBIT NO. EXHIBITS
3.1* --- Amended and Restated Certificate of Incorporation of the Company
3.2* --- Amended and Restated Bylaws of the Company
22** --- Definitive Proxy Statement pursuant to Section 14(a) of the Securities
Exchange Act of 1934.
27*** --- Financial Data Schedule
* Previously filed in connection with the Company's Registration Statement
on Form S-1 filed October 8, 1996 (No. 333-06931).
** Previously filed on July 29, 1998 (No.000-21447).
*** Filed herewith.
- 13 -
<PAGE> 15
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
ADVANCE PARADIGM, INC.
(Registrant)
Date: November 12, 1998 By: /s/ David D. Halbert
------------------------------------------
David D. Halbert, Chief Executive Officer,
Chairman of the Board and President
Date: November 12, 1998 By: /s/ Danny Phillips
------------------------------------------
Danny Phillips, Chief Financial Officer,
Senior Vice President, Secretary and
Treasurer (Principal Financial and
Accounting Officer)
- 14 -
<PAGE> 16
Exhibit Index
Exhibits required by Item 601 of S-K:
<TABLE>
<CAPTION>
EXHIBIT NO. EXHIBITS
- ----------- --------
<S> <C> <C>
3.1* --- Amended and Restated Certificate of Incorporation of the Company
3.2* --- Amended and Restated Bylaws of the Company
22** --- Definitive Proxy Statement pursuant to Section 14(a) of the Securities
Exchange Act of 1934.
27*** --- Financial Data Schedule
</TABLE>
* Previously filed in connection with the Company's Registration Statement
on Form S-1 filed October 8, 1996 (No. 333-06931).
** Previously filed on July 29, 1998 (No.000-21447).
*** Filed herewith.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE ADVANCE
PARADIGM, INC. FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1998 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-31-1999
<PERIOD-START> APR-01-1998
<PERIOD-END> SEP-30-1998
<CASH> 38,106
<SECURITIES> 0
<RECEIVABLES> 97,709
<ALLOWANCES> 259
<INVENTORY> 2,591
<CURRENT-ASSETS> 139,935
<PP&E> 18,972
<DEPRECIATION> 6,909
<TOTAL-ASSETS> 165,102
<CURRENT-LIABILITIES> 106,154
<BONDS> 0
0
0
<COMMON> 103
<OTHER-SE> 56,817
<TOTAL-LIABILITY-AND-EQUITY> 165,102
<SALES> 0
<TOTAL-REVENUES> 345,440
<CGS> 0
<TOTAL-COSTS> 330,869
<OTHER-EXPENSES> 6,575
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (1,474)
<INCOME-PRETAX> 9,470
<INCOME-TAX> 3,598
<INCOME-CONTINUING> 5,872
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,872
<EPS-PRIMARY> .58
<EPS-DILUTED> .51
</TABLE>
